期刊档案

Zhurnal organichnoyi ta farmatsevtichnoyi khimiyi

ISSN 2308-8303 · eISSN 2518-1548 · National University of Pharmacy (Kharkiv, Ukraine) · Ukraine

Zhurnal organichnoyi ta farmatsevtichnoyi khimiyi 钻石开放获取(无 APC),免版面费,投稿社区反馈审稿约 7 周,2025 年发文 20 篇。

官网最新一期停留在 2020 年(Volume 18, Issue 4),近两年可能未再出刊或已迁移平台,投稿前请到官网核实。

影响因子—暂无公布值
中科院分区—未被分区表收录
CiteScore 分区—暂无 CiteScore 排名
审稿周期约 7 周投稿社区平均反馈
版面费免版面费钻石开放获取(无 APC)
录用比例—暂无反馈
年发文量20 篇2025 年 · OpenAlex 统计

研究范围

研究范围与定位

Zhurnal organichnoyi ta farmatsevtichnoyi khimiyi 由 National University of Pharmacy (Kharkiv, Ukraine) 出版。按 OpenAlex 近年发文统计,该刊主要发表 Synthesis and biological activity、Synthesis and Characterization of Heterocyclic Compounds、Structural and Chemical Analysis of Organic and Inorganic Compounds 等主题的论文,这 3 个主题约占 34.7%,主导子领域为 Organic Chemistry。(根据 OpenAlex 主题统计与中科院分区数据生成)

The Journal of Organic and Pharmaceutical Chemistry invites original research articles that make fundamental contributions to all areas of organic, medicinal, and natural products chemistry, encompassing both theoretical and practical aspects. In selecting manuscripts for publication, the editors prioritize scientific quality, originality, and relevance to a broad audience within the field of chemistry.While the journal highlights specific research areas outlined below, it remains open to submissions across the full spectrum of organic chemistry. The Editorial Board actively encourages and evaluates manuscripts that extend beyond these categories. THEMATIC AREAS OF FOCUS INCLUDE:1. Synthetic Methodology: Studies describing single- or multistep syntheses, including total syntheses, that introduce novel strategies, key transformations, or significantly streamlined routes to target molecules with clear conceptual innovation.2. Mechanistic Investigations: Experimental or theoretical work that advances understanding of chemical reaction mechanisms or introduces novel methodological approaches.3. Natural Product Chemistry: Research on the isolation and structural elucidation of natural products, particularly those with unusual skeletal features, methodological innovations in structure determination, or insights into biosynthetic pathways.4. Chemical analysis: Development, optimization, and validation of analytical methods for the qualitative and quantitative analysis of chemicals, including active pharmaceutical ingredients (APIs), drug products, dietary supplements, and bioactive compounds; standardization and quality control of pharmaceutical products; development and validation of bioanalytical methods for toxicological analysis, pharmacokinetic studies, and related applications.5. Chemical informatics: Research involving chemical informatics, molecular modeling, and simulation, where computational results are validated or contextualized through experimental or theoretical insight relevant to organic chemistry.6: Biopharmaceutical Chemistry: Research focused on the biological evaluation of organic compounds, structure–activity relationships, and applications relevant to drug discovery and development.7. Interdisciplinary Studies: Manuscripts that integrate elements of biology, analytical chemistry, functional molecules and systems, or materials science must clearly demonstrate originality in the organic chemistry component of the work. The journal is intended

摘自期刊官网 Aims & Scope

主编 MYKHAYLO V. VOVK出版商官网

编委会国家分布:未见中国大陆编委;主要国家 乌克兰 25、英国 1、法国 1、波兰 1、埃及 1(共 31 位编委标注了国家) 编委会 ↗出版商官网 ·

主要研究主题 OpenAlex 近年发文统计,占比为近似值

  1. Synthesis and biological activityChemistry14%
  2. Synthesis and Characterization of Heterocyclic CompoundsChemistry12.3%
  3. Structural and Chemical Analysis of Organic and Inorganic CompoundsChemistry8.3%
  4. Synthesis of heterocyclic compoundsChemistry8.3%
  5. Chemical synthesis and pharmacological studiesChemistry7.1%
  6. Analytical Methods in PharmaceuticalsChemistry6%
  7. Synthesis and Biological EvaluationChemistry3.6%
  8. Fluorine in Organic ChemistryPharmacology, Toxicology and Pharmaceutics3.2%

分区与收录

学科分区与数据库收录

中科院期刊分区表

期刊分区表( 2025年3月升级版)未收录

该期刊未被此版本分区表收录。

《新锐期刊分区表》( 2026年3月发布)未收录

该期刊未被此版本分区表收录。

期刊分区表( 2023年12月旧的升级版)未收录

该期刊未被此版本分区表收录。

数据库收录

DOAJLetPub

国际期刊预警名单:各版本均未列入LetPub

期刊官网自述收录

CAS出版商官网

其他:Index Copernicus、Bielefeld Academic Search Engine (BASE)、Directory of Open Access Scholarly Resources (ROAD)、PKP Index、Ulrich’s Periodicals Directory、WorldCat、National Library of Ukraine named after V.I. Vernadsky、Ukrainian Abstract Journal "Dzherelo" ("Source")

期刊官网列出的收录清单,未与各数据库逐一核对;Web of Science 各子库以上方记录为准。

不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。

指标

影响力指标与发文规模

影响力指标

h-index
7OpenAlex ·
i10-index
3OpenAlex ·
两年平均被引
0.32OpenAlex ·
Gold OA 文章占比
0%LetPub ·

逐年发文量 OpenAlex 统计 · 累计 387 篇 · 当年数据不完整

年份发文量其中 OA被引
2026171753
2025202061
2024191956
2023292987
2022191953
2021303042

不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。

审稿与录用

审稿周期与录用情况

平均审稿速度(社区反馈)
7 WeeksLetPub ·
投稿到发表(期刊自报)
约 7 周DOAJ ·
评审方式
单盲同行评审DOAJ

社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。

费用与开放获取

版面费与开放获取政策

钻石开放获取(无 APC)DOAJ

所有文章开放获取,且不向作者收取文章处理费。

来源文章处理费费用减免许可证观测时间
DOAJ无文章处理费无CC BY
OpenAlexUAH 850——
LetPubUAH 850无—
出版商官网有,金额未公布——

费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。

投稿要求

文章类型与投稿政策(官网)

投稿准备要点4 项,摘自作者指南
关键词
≥ 5 个
参考文献格式
ACS 格式
推荐审稿人
可选
投稿信(Cover letter)
必须提供
出版商官网 · 模型提取,逐项与原文核对
接收的文章类型4 种
  1. original research articlesThe Editorial Board considers original research articles, review articles, and short communications (see Manuscript types).未说明篇幅
  2. original researchesOriginal Researches The synthesis, transformations and biological activity of thieno[2,3-d]pyrimidine derivatives with the carboxylic groups as the substituents…未说明篇幅
  3. review articlesThe Editorial Board considers original research articles, review articles, and short communications (see Manuscript types).未说明篇幅
  4. short communicationsThe Editorial Board considers original research articles, review articles, and short communications (see Manuscript types).未说明篇幅
出版商官网
官网政策摘录AI 使用、作者资格、利益冲突、许可与版权、开放获取、同行评审、查重、预印本
AI 使用 POLICY ON THE USE OF GENERATIVE AI

Purpose and Scope This policy outlines the ethical use, disclosure requirements, and editorial oversight concerning the application of Generative AI (GenAI) and AI-assisted technologies in the preparation, submission, peer review, and editorial processes of the Journal content. It is aligned with practices recommended by bodies such as the Committee on Publication Ethics (COPE). Definition of Gene…

原文 ↗出版商官网 ·
作者资格 3.3. Authorship and Responsibility

GenAI tools must not be listed as authors or co-authors, as they cannot take responsibility for the integrity, originality, and ethical compliance of scholarly work. Authorship implies the ability to:

原文 ↗出版商官网 ·
利益冲突 3.2. Transparency and Disclosure

Conflict of interest statement required; Elsevier disclosure standards. 模型摘要

All authors are required to disclose any use of GenAI or AI-assisted technologies in the preparation of their work. The disclosure must specify:

原文 ↗出版商官网 ·
许可与版权 Copyright Notice

Copyright retained by authors; first publication under CC BY 4.0. 模型摘要

Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms: 1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License (CC BY 4.0) allowing everyone to distribute and re-use the published material if proper citation of the original publication is given. 2. Auth…

原文 ↗出版商官网 ·
开放获取 OPEN ACCESS POLICY

The Editorial Board of the Journal of Organic and Pharmaceutical Chemistry adheres to the principle that open-access publishing fosters the exchange of research results among scientists from different disciplines, thereby facilitating interdisciplinary research. All articles published in the Journal of Organic and Pharmaceutical Chemistry are made immediately available worldwide under an open-acce…

原文 ↗出版商官网 ·
同行评审 PEER REVIEW PROCESS

The Journal of Organic and Pharmaceutical Chemistry is a peer-reviewed publication that employs a single-blind review process, in which the authors do not know the identities of the reviewers. Manuscripts are evaluated by independent experts in the relevant field to ensure scholarly integrity and quality. Before being sent for review, each submission undergoes a preliminary assessment by the execu…

原文 ↗出版商官网 ·
查重 PLAGIARISM

The editorial team of the Journal of Organic and Pharmaceutical Chemistry is committed to publishing only original research and strictly adheres to policies aimed at preventing all forms of plagiarism, including self-plagiarism. To support this commitment, all submitted manuscripts are screened during the submission process at the Institute of Organic Chemistry of the National Academy of Sciences …

原文 ↗出版商官网 ·
预印本

Preprint/self-archiving permitted prior to and during submission. 模型摘要

Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work

原文 ↗出版商官网 ·

摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。

基本信息

出版信息与官方入口

出版商
National University of Pharmacy (Kharkiv, Ukraine)
出版国家或地区
Ukraine
出版语言
English, Ukrainian, Russian
ISSN
2308-8303
电子版 ISSN
2518-1548
官网最新一期
Volume 18, Issue 4(2020 年)
官方链接

常见问题

关于 Zhurnal organichnoyi ta farmatsevtichnoyi khimiyi 的常见问题

Zhurnal organichnoyi ta farmatsevtichnoyi khimiyi 的审稿周期多长?

投稿社区反馈的平均审稿速度为约 7 周。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。

Zhurnal organichnoyi ta farmatsevtichnoyi khimiyi 的投稿格式要求是什么?

据期刊作者指南:关键词:≥ 5 个;参考文献格式:ACS 格式;推荐审稿人:可选;投稿信:必须提供。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。

Zhurnal organichnoyi ta farmatsevtichnoyi khimiyi 的编委会里有中国学者吗?

期刊官网编委会页面上标注了国家的 31 位编委中,没有中国大陆学者;人数最多的国家是 乌克兰(25 位)、英国(1 位)、法国(1 位)。统计按编委会页面列出的机构国家计,仅供参考。

Zhurnal organichnoyi ta farmatsevtichnoyi khimiyi 被哪些数据库收录?

据 LetPub 与 DOAJ 记录,Zhurnal organichnoyi ta farmatsevtichnoyi khimiyi 被 DOAJ 收录。期刊官网自述还被 CAS 收录,该清单未与各数据库逐一核对。

Zhurnal organichnoyi ta farmatsevtichnoyi khimiyi 是开放获取期刊吗?版面费多少?

Zhurnal organichnoyi ta farmatsevtichnoyi khimiyi 为钻石开放获取(无 APC)。不收取文章处理费。

来源与更新

本页事实来自 LetPub、OpenAlex、DOAJ、出版商官网;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-26 归档)。最近更新:。